Press Releases - 2011

Moffitt Cancer Center Participates in Nationwide Study Offering Lung Tumor Genetic Testing

Moffitt Cancer Center is one of 14 medical sites participating in a national study that offers advanced lung cancer patients screening of their tumors for genetic mutations.

Moffitt Cancer Center Seeks Participants For Pancreatic Cystic Tumor Research Study

Dr. Shivakumar Vignesh is searching for people who have pancreatic cystic tumors to participate in a research study at Moffitt Cancer Center.

Moffitt Cancer Center Researchers Unravel A Biochemical Factor Important In Tumor Metastasis

A protein called “fascin” appears to play a critical transformation role in TGF beta mediated tumor metastasis, say researchers at Moffitt Cancer Center in Tampa, Fla., who published a study in a recent issue of the Journal of Biological Chemistry.

Moffitt Cancer Center Researchers Find Men Less Willing To Be Screened For Cancer

Although men have higher cancer mortality rates than women, they are less willing to be screened for cancer, according to a study conducted by researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Sanoa Consulting LLC, Muscle Shoals, Ala., and the New York University College of Dentistry.

Moffitt Cancer Center Hosts 5th Annual Business of Biotech Conference

Moffitt Cancer Center will host its fifth-annual Business of Biotech conference from 8 a.m. to 1:30 p.m. Jan. 31 in the Vincent A. Stabile Research Building, 12902 Magnolia Drive.

Moffitt Cancer Center Offers Targeted Radiopharmaceutical Therapy

Moffitt Cancer Center has one of the highest volumes in the country when it comes to offering a type of “liquid radiation” to patients with lymphoma or with cancer that has spread to their bones from their primary tumor.

Moffitt Cancer Center Researchers Find MK1775 Active Against Sarcomas

MK 1775, a small, selective inhibitor molecule, has been found to be active against many sarcomas when tested by researchers at Moffitt Cancer Center in Tampa, Fla.

Moffitt Cancer Center researchers will have a strong participation in American Society of Hematology

When the American Society of Hematology convenes its 53rd Annual Meeting and Exposition on Dec. 10-13 in San Diego, Calif., researchers from Moffitt Cancer Center will break a new record for Moffitt participants with one plenary presentation, 16 oral presentations and more than 50 poster presentations on new research results in a variety of meeting programs that focus on blood cancer basic science and clinical applications, including bone marrow transplantation and clinical trials results.

Moffitt Cancer Center researchers will have a strong participation in American Society of Hematology

When the American Society of Hematology convenes its 53rd Annual Meeting and Exposition on Dec. 10-13 in San Diego, Calif., researchers from Moffitt Cancer Center will break a new record for Moffitt participants with one plenary presentation, 16 oral presentations and more than 50 poster presentations on new research results in a variety of meeting programs that focus on blood cancer basic science and clinical applications, including bone marrow transplantation and clinical trials results.

Moffitt Cancer Center Follow-Up Study Finds Prolonged Fatigue For Those Who Received Chemotherapy For Breast Cancer

In a follow-up study, researchers at Moffitt Cancer Center and colleagues have found that patients who receive chemotherapy for breast cancer might experience prolonged fatigue years after their therapy.